Evotec Enters Into Medicinal Chemistry Agreement With Mitsubishi

Evotec OAI AG, a leading partner for integrated high-value-added drug discovery and development solutions to the pharmaceutical and biotechnology industries, has announced that it will support Mitsubishi Pharma, Osaka, Japan, in its medicinal chemistry programs. Using its world-class computational chemistry, parallel synthesis and medicinal chemistry expertise, Evotec OAI will support MPC in rapidly advancing compound hit series identified by MPC for their drug targets.

Yahoo News (http://biz.yahoo.com/prnews/050228/ukm008_1.html)